(NMRK) Newmark - Overview
Stock: Capital Markets, Leasing, Valuation, Property Management, Advisory
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.83% |
| Yield on Cost 5y | 1.51% |
| Yield CAGR 5y | 31.61% |
| Payout Consistency | 83.4% |
| Payout Ratio | 12.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 43.2% |
| Relative Tail Risk | -7.74% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.60 |
| Alpha | 1.46 |
| Character TTM | |
|---|---|
| Beta | 1.263 |
| Beta Downside | 1.515 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.51% |
| CAGR/Max DD | 0.63 |
Description: NMRK Newmark January 12, 2026
Newmark Group, Inc. (NASDAQ: NMRK) is a full-service commercial real-estate firm operating in the United States, United Kingdom and other international markets. Its platform spans capital-markets activities (investment sales, commercial mortgage brokerage), landlord and tenant leasing, valuation, property management, and a suite of advisory services that include energy-sustainability, workplace strategy, and flexible-workspace solutions for owners and occupiers.
For FY 2023 the company reported revenue of roughly $2.2 billion, up about 7 % year-over-year, with adjusted EBITDA margin hovering near 14 %. Growth has been driven by strong demand for flexible-workspace and technology-enabled brokerage services, while the broader CRE sector remains sensitive to macro-factors such as the Federal Reserve’s interest-rate policy and elevated office vacancy rates that are reshaping leasing activity.
If you want a deeper, data-rich view of Newmark’s valuation dynamics, a quick look at ValueRay’s analyst dashboards can help surface the most material assumptions and scenario analyses.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: 103.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA 3.53 > 1.0 |
| NWC/Revenue: 2.23% < 20% (prev 1.19%; Δ 1.04% < -1%) |
| CFO/TA -0.01 > 3% & CFO -43.9m > Net Income 103.6m |
| Net Debt (2.44b) to EBITDA (391.6m): 6.22 < 3 |
| Current Ratio: 1.03 > 1.5 & < 3 |
| Outstanding Shares: last quarter (253.2m) vs 12m ago -0.70% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 60.41% > 50% (prev 52.22%; Δ 8.19% > 0%) |
| Interest Coverage Ratio: 3.11 > 6 (EBITDA TTM 391.6m / Interest Expense TTM 68.9m) |
Altman Z'' 1.45
| A: 0.01 (Total Current Assets 2.44b - Total Current Liabilities 2.37b) / Total Assets 5.46b |
| B: 0.23 (Retained Earnings 1.25b / Total Assets 5.46b) |
| C: 0.04 (EBIT TTM 214.4m / Avg Total Assets 5.23b) |
| D: 0.33 (Book Value of Equity 1.25b / Total Liabilities 3.84b) |
| Altman-Z'' Score: 1.45 = BB |
Beneish M -3.01
| DSRI: 0.84 (Receivables 596.3m/585.3m, Revenue 3.16b/2.61b) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.95 (AQ_t 0.44 / AQ_t-1 0.46) |
| SGI: 1.21 (Revenue 3.16b / 2.61b) |
| TATA: 0.03 (NI 103.6m - CFO -43.9m) / TA 5.46b) |
| Beneish M-Score: -3.01 (Cap -4..+1) = AA |
What is the price of NMRK shares?
Over the past week, the price has changed by -5.50%, over one month by -4.15%, over three months by -1.11% and over the past year by +22.04%.
Is NMRK a buy, sell or hold?
- StrongBuy: 1
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the NMRK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 21 | 24.6% |
| Analysts Target Price | 21 | 24.6% |
| ValueRay Target Price | 18.5 | 9.7% |
NMRK Fundamental Data Overview February 03, 2026
P/E Forward = 5.7405
P/S = 1.4239
P/B = 2.3398
Revenue TTM = 3.16b USD
EBIT TTM = 214.4m USD
EBITDA TTM = 391.6m USD
Long Term Debt = 746.5m USD (from longTermDebt, last quarter)
Short Term Debt = 1.45b USD (from shortTermDebt, last quarter)
Debt = 2.66b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.44b USD (from netDebt column, last quarter)
Enterprise Value = 6.94b USD (4.50b + Debt 2.66b - CCE 224.1m)
Interest Coverage Ratio = 3.11 (Ebit TTM 214.4m / Interest Expense TTM 68.9m)
EV/FCF = -120.0x (Enterprise Value 6.94b / FCF TTM -57.8m)
FCF Yield = -0.83% (FCF TTM -57.8m / Enterprise Value 6.94b)
FCF Margin = -1.83% (FCF TTM -57.8m / Revenue TTM 3.16b)
Net Margin = 3.28% (Net Income TTM 103.6m / Revenue TTM 3.16b)
Gross Margin = unknown ((Revenue TTM 3.16b - Cost of Revenue TTM -15.6m) / Revenue TTM)
Tobins Q-Ratio = 1.27 (Enterprise Value 6.94b / Total Assets 5.46b)
Interest Expense / Debt = 1.62% (Interest Expense 43.0m / Debt 2.66b)
Taxrate = 24.27% (18.7m / 77.2m)
NOPAT = 162.3m (EBIT 214.4m * (1 - 24.27%))
Current Ratio = 1.03 (Total Current Assets 2.44b / Total Current Liabilities 2.37b)
Debt / Equity = 1.94 (Debt 2.66b / totalStockholderEquity, last quarter 1.37b)
Debt / EBITDA = 6.22 (Net Debt 2.44b / EBITDA 391.6m)
Debt / FCF = -42.14 (negative FCF - burning cash) (Net Debt 2.44b / FCF TTM -57.8m)
Total Stockholder Equity = 1.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.98% (Net Income 103.6m / Total Assets 5.46b)
RoE = 8.01% (Net Income TTM 103.6m / Total Stockholder Equity 1.29b)
RoCE = 10.51% (EBIT 214.4m / Capital Employed (Equity 1.29b + L.T.Debt 746.5m))
RoIC = 5.22% (NOPAT 162.3m / Invested Capital 3.11b)
WACC = 7.10% (E(4.50b)/V(7.16b) * Re(10.57%) + D(2.66b)/V(7.16b) * Rd(1.62%) * (1-Tc(0.24)))
Discount Rate = 10.57% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 20.88%
Fair Price DCF = unknown (Cash Flow -57.8m)
EPS Correlation: -21.85 | EPS CAGR: -48.93% | SUE: -4.0 | # QB: 0
Revenue Correlation: 9.87 | Revenue CAGR: -3.44% | SUE: 2.88 | # QB: 4
EPS next Quarter (2026-03-31): EPS=0.25 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=6
EPS next Year (2026-12-31): EPS=1.86 | Chg30d=+0.012 | Revisions Net=+2 | Growth EPS=+16.8% | Growth Revenue=+10.3%